The National Cancer Director, Professor Mike Richards, has undertaken his third analysis of usage of cancer drugs approved by the National Institute for Health and Clinical Excellence. The findings were made available in chapter 4 of the first report of the Cancer Reform Strategy, “Cancer Reform Strategy: Maintaining momentum, building for the future—first annual report”, published on 1 December 2008. This document has already been placed in the Library.